<DOC>
	<DOC>NCT02147249</DOC>
	<brief_summary>The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.</brief_summary>
	<brief_title>Cytokines and Chemokines in Erythema Migrans</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Erythema Chronicum Migrans</mesh_term>
	<mesh_term>Glossitis, Benign Migratory</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<criteria>erythema migrans in patients &gt; 18 years pregnancy or lactation taking antibiotic with antiborrelial activity within 10 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>erythema migrans</keyword>
	<keyword>Lyme borreliosis</keyword>
	<keyword>inflammation</keyword>
	<keyword>outcome</keyword>
</DOC>